Clozapine: The Gold Standard for Treatment-Resistant Schizophrenia
Psychopharmacology and Psychiatry Updates
by Psychopharmacology Institute
3d ago
In this episode, we delve into the use of clozapine for treatment-resistant psychosis and mood disorders. When should clinicians consider clozapine, and what do expert guidelines recommend? Dr. Brian Miller guides us through the evidence and best practices for utilizing this powerful but often underused medication. Faculty: Brian Miller, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Clozapine: Management and Challenges Using Clozapine for Treatment-Resistant Psychosis and Mood Disorders ..read more
Visit website
Balancing Benefits and Risks: Lithium in Child and Adolescent Psychiatry
Psychopharmacology and Psychiatry Updates
by Psychopharmacology Institute
1w ago
In this episode, we explore the role of lithium in treating pediatric bipolar disorder and conduct disorder. Is lithium a viable option for managing these complex conditions in children and adolescents, or are other medications more effective? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 14 Use of Lithium in Pediatric Bipolar Disorders and Externalizing Childhood-Related Disorders ..read more
Visit website
Orchestrating Nutrition and Medication: Micronutrient Therapy in Practice
Psychopharmacology and Psychiatry Updates
by Psychopharmacology Institute
1w ago
In this episode, we explore real-world clinical cases demonstrating how broad-spectrum micronutrients can complement existing interventions for ADHD, emotional dysregulation, and mood instability. Can close monitoring and expert guidance optimize the integration of nutritional supplementation with pharmacologic treatments to create a harmonious, personalized approach? Faculty: Amelia Villagomez, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CMEs: Broad-Spectrum Micronutrients (BSMs) for Mental Health: What You Need to Know for Clinical Use Clinical Cases ..read more
Visit website
Zuranolone: A New Dawn for Postpartum Depression Treatment
Psychopharmacology and Psychiatry Updates
by Psychopharmacology Institute
2w ago
In this episode, we discuss the groundbreaking FDA approval of zuranolone, the first oral medication specifically targeting postpartum depression. Could zuranolone's novel mechanism of action as an allopregnanolone agonist herald a new era of rapid-onset, targeted treatments for this debilitating condition affecting 1 in 8 new mothers? Faculty: Vivien Burt, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 54 Zuranolone for the Treatment of Postpartum Depression ..read more
Visit website
Micronutrients for Psychiatric Disorders: Optimizing Clinical Use
Psychopharmacology and Psychiatry Updates
by Psychopharmacology Institute
3w ago
In this episode, we explore practical clinical tips for using broad-spectrum micronutrient supplements to treat mental health conditions. Can an individual's nutritional needs surpass population standards? Faculty: Amelia Villagomez, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Broad-Spectrum Micronutrients (BSMs) for Mental Health: What You Need to Know for Clinical Use Practical Tips for Using BSMs in the Clinical Practice ..read more
Visit website
Olanzapine in Pregnancy: Examining the Risks
Psychopharmacology and Psychiatry Updates
by Psychopharmacology Institute
1M ago
In this episode, we examine whether first-trimester exposure to the antipsychotic olanzapine increases the risk of major fetal malformations. Does stopping medication abruptly also carry risks? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 14 Risk of Major Malformations Following First-Trimester Exposure to Olanzapine ..read more
Visit website
Understanding Safety Risks of Broad-Spectrum Micronutrients
Psychopharmacology and Psychiatry Updates
by Psychopharmacology Institute
1M ago
In this episode, we delve into the safety considerations of using broad-spectrum micronutrient formulas in mental disorder treatment, mainly how these supplements can interact with other medications. Is it safe to use these formulas alongside anesthesia during surgery? Faculty: Amelia Villagomez, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Broad-Spectrum Micronutrients (BSMs) for Mental Health: What You Need to Know for Clinical Use BSMs and Drug Interactions ..read more
Visit website
The Role of Inflammation in Delirium: Can NSAIDs Help?
Psychopharmacology and Psychiatry Updates
by Psychopharmacology Institute
1M ago
In this episode, we explore the potential of NSAIDs in delirium prevention. However, NSAIDs come with risks, such as GI bleeding or kidney injury. Can NSAIDs really help prevent delirium, and if so, how? Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 54 Use of NSAIDs for Delirium Risk Reduction ..read more
Visit website
Beyond Medication: Exploring Nutritional Psychiatry
Psychopharmacology and Psychiatry Updates
by Psychopharmacology Institute
1M ago
In this episode, we explore the unconventional yet promising treatment modality of using broad-spectrum micronutrient formulas in mental health care. We discuss the research and clinical trials that have been undertaken to test combinations of vitamins and minerals, focusing on their safety and efficacy. What are the potential side effects of using broad-spectrum micronutrient formulas? Faculty: Amelia Villagomez, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Broad-Spectrum Micronutrients (BSMs) for Mental Health: What You Need to Know for Clinical Use B ..read more
Visit website
Age Impact on Antidepressant Outcomes
Psychopharmacology and Psychiatry Updates
by Psychopharmacology Institute
1M ago
In this episode, we discuss an insightful study by Strawn et al. that utilized a mega-analysis approach, combining data on over 900 MDD patients across lifespan treatment trials to elucidate differences in antidepressant treatment outcomes based on patient age. Does antidepressant efficacy differ across developmental stages—children, adolescents, and adults? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 13 Age's Impact on Antidepressant Response ..read more
Visit website

Follow Psychopharmacology and Psychiatry Updates on FeedSpot

Continue with Google
Continue with Apple
OR